Lithium chloride stimulates plp and mbp expression in oligodendrocytes via wnt/β-catenin and akt/creb pathways

Neuroscience

Volumn 284, Issue , 2015, Pages 962-971

  Meffre, D ^a   Massaad, C ^a   Grenier, J ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Akt CREB; Lithium chloride; Oligodendrocytes; Remyelination; Wnt catenin

Indexed keywords

BETA CATENIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; LITHIUM CHLORIDE; LYSOPHOSPHATIDYLCHOLINE; MESSENGER RNA; MYELIN BASIC PROTEIN; PROTEIN KINASE B; PROTEOLIPID PROTEIN; WNT PROTEIN; CREB1 PROTEIN, MOUSE; CTNNB1 PROTEIN, MOUSE; MBP PROTEIN, MOUSE; NEUROPROTECTIVE AGENT; PLP1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BRAIN SLICE; CELL MATURATION; CONTROLLED STUDY; DEMYELINATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; MBP GENE; MOUSE; NERVE CELL STIMULATION; NONHUMAN; OLIGODENDROGLIA; PLP GENE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REMYELINIZATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; BRAIN; C57BL MOUSE; CELL CULTURE; CELL LINE; DEMYELINATING DISEASES; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TISSUE CULTURE TECHNIQUE; TRANSGENIC MOUSE;

ANIMALS; BETA CATENIN; BRAIN; CELL LINE; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; LITHIUM CHLORIDE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELIN BASIC PROTEIN; MYELIN PROTEOLIPID PROTEIN; NEUROPROTECTIVE AGENTS; OLIGODENDROGLIA; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUES; WNT PROTEINS;

EID: 84913555312     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.10.064     Document Type: Article

References (45)

1. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998, 281:1322-1326.
2. Afshari F.S., Chu A.K., Sato-Bigbee C. Effect of cyclic AMP on the expression of myelin basic protein species and myelin proteolipid protein in committed oligodendrocytes: differential involvement of the transcription factor CREB. J Neurosci Res 2001, 66:37-45.
3. Azim K., Butt A.M. GSK3beta negatively regulates oligodendrocyte differentiation and myelination in vivo. Glia 2011, 59:540-553.
4. Azim K., Fischer B., Hurtado-Chong A., Draganova K., Cantu C., Zemke M., Sommer L., Butt A., Raineteau O. Persistent Wnt/beta-catenin signaling determines dorsalization of the postnatal subventricular zone and neural stem cell specification into oligodendrocytes and glutamatergic neurons. Stem Cells 2014, 32:1301-1312.
5. Azim K., Rivera A., Raineteau O., Butt A.M. GSK3beta regulates oligodendrogenesis in the dorsal microdomain of the subventricular zone via Wnt-beta-catenin signaling. Glia 2014, 62:778-779.
6. Barateiro A., Fernandes A. Temporal oligodendrocyte lineage progression: in vitro models of proliferation, differentiation and myelination. Biochim Biophys Acta 2014.
7. Beurel E., Jope R.S. The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog Neurobiol 2006, 79:173-189.
8. Blanchard B., Heurtaux T., Garcia C., Moll N.M., Caillava C., Grandbarbe L., Klosptein A., Kerninon C., Frah M., Coowar D., Baron-Van Evercooren A., Morga E., Heuschling P., Nait Oumesmar B. Tocopherol derivative TFA-12 promotes myelin repair in experimental models of multiple sclerosis. J Neurosci 2013, 33:11633-11642.
9. Chalecka-Franaszek E., Chuang D.M. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci U S A 1999, 96:8745-8750.
10. Chuang D.M. Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?. Crit Rev Neurobiol 2004, 16:83-90.
11. Chuang D.M. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Ann N Y Acad Sci 2005, 1053:195-204.
12. Dai Z.M., Sun S., Wang C., Huang H., Hu X., Zhang Z., Lu Q.R., Qiu M. Stage-specific regulation of oligodendrocyte development by Wnt/beta-catenin signaling. J Neurosci 2014, 34:8467-8473.
13. De Sarno P., Axtell R.C., Raman C., Roth K.A., Alessi D.R., Jope R.S. Lithium prevents and ameliorates experimental autoimmune encephalomyelitis. J Immunol 2008, 181:338-345.
14. Du K., Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 1998, 273:32377-32379.
15. El Waly B., Macchi M., Cayre M., Durbec P. Oligodendrogenesis in the normal and pathological central nervous system. Front Neurosci 2014, 8:145.
16. Fancy S.P., Baranzini S.E., Zhao C., Yuk D.I., Irvine K.A., Kaing S., Sanai N., Franklin R.J., Rowitch D.H. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 2009, 23:1571-1585.
17. Feutz A.C., Pham-Dinh D., Allinquant B., Miehe M., Ghandour M.S. An immortalized jimpy oligodendrocyte cell line: defects in cell cycle and cAMP pathway. Glia 2001, 34:241-252.
18. Flores A.I., Narayanan S.P., Morse E.N., Shick H.E., Yin X., Kidd G., Avila R.L., Kirschner D.A., Macklin W.B. Constitutively active Akt induces enhanced myelination in the CNS. J Neurosci 2008, 28:7174-7183.
19. Fonte C., Grenier J., Trousson A., Chauchereau A., Lahuna O., Baulieu E.E., Schumacher M., Massaad C. Involvement of {beta}-catenin and unusual behavior of CBP and p300 in glucocorticosteroid signaling in Schwann cells. Proc Natl Acad Sci U S A 2005, 102:14260-14265.
20. Frohman E., Costello F., Zivadinov R., Stuve O., Conger A., Winslow H., Trip A., Frohman T., Balcer L. Optical coherence tomography in multiple sclerosis. Lancet Neurol 2006, 5:853-863.
21. Galimberti D., Macmurray J., Scalabrini D., Fenoglio C., De Riz M., Comi C., Comings D., Cortini F., Villa C., Serpente M., Cantoni C., Ridolfi E., Fardipoor M.H., Leone M., Monaco F., Bresolin N., Scarpini E. GSK3beta genetic variability in patients with Multiple Sclerosis. Neurosci Lett 2011, 497:46-48.
22. Guardiola-Diaz H.M., Ishii A., Bansal R. Erk1/2 MAPK and mTOR signaling sequentially regulates progression through distinct stages of oligodendrocyte differentiation. Glia 2012, 60:476-486.
23. Huang J.K., Franklin R.J. Regenerative medicine in multiple sclerosis: identifying pharmacological targets of adult neural stem cell differentiation. Neurochem Int 2011, 59:329-332.
24. Huang J.K., Jarjour A.A., Nait Oumesmar B., Kerninon C., Williams A., Krezel W., Kagechika H., Bauer J., Zhao C., Baron-Van Evercooren A., Chambon P., Ffrench-Constant C., Franklin R.J. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat Neurosci 2011, 14:45-53.
25. Hussain R., El-Etr M., Gaci O., Rakotomamonjy J., Macklin W.B., Kumar N., Sitruk-Ware R., Schumacher M., Ghoumari A.M. Progesterone and Nestorone facilitate axon remyelination: a role for progesterone receptors. Endocrinology 2011, 152:3820-3831.
26. Jorda E.G., Verdaguer E., Canudas A.M., Jimenez A., Garcia de Arriba S., Allgaier C., Pallas M., Camins A. Implication of cyclin-dependent kinase 5 in the neuroprotective properties of lithium. Neuroscience 2005, 134:1001-1011.
27. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A 1996, 93:8455-8459.
28. Lai W.S., Xu B., Westphal K.G., Paterlini M., Olivier B., Pavlidis P., Karayiorgou M., Gogos J.A. Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning. Proc Natl Acad Sci U S A 2006, 103:16906-16911.
29. Luo F., Burke K., Kantor C., Miller R.H., Yang Y. Cyclin-dependent kinase 5 mediates adult OPC maturation and myelin repair through modulation of Akt and GsK-3beta signaling. J Neurosci 2014, 34:10415-10429.
30. Makoukji J., Belle M., Meffre D., Stassart R., Grenier J., Shackleford G., Fledrich R., Fonte C., Branchu J., Goulard M., de Waele C., Charbonnier F., Sereda M.W., Baulieu E.E., Schumacher M., Bernard S., Massaad C. Lithium enhances remyelination of peripheral nerves. Proc Natl Acad Sci U S A 2012, 109:3973-3978.
31. Mallon B.S., Shick H.E., Kidd G.J., Macklin W.B. Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J Neurosci 2002, 22:876-885.
32. Martin M., Rehani K., Jope R.S., Michalek S.M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 2005, 6:777-784.
33. Massaad C., Garlatti M., Wilson E.M., Cadepond F., Barouki R. A natural sequence consisting of overlapping glucocorticoid-responsive elements mediates glucocorticoid, but not androgen, regulation of gene expression. Biochem J 2000, 350(Pt 1):123-129.
34. Meffre D., Grenier J., Bernard S., Courtin F., Dudev T., Shackleford G., Jafarian-Tehrani M., Massaad C. Wnt and lithium: a common destiny in the therapy of nervous system pathologies?. Cell Mol Life Sci 2013.
35. Miller R.H. Regulation of oligodendrocyte development in the vertebrate CNS. Prog Neurobiol 2002, 67:451-467.
36. Narayanan S.P., Flores A.I., Wang F., Macklin W.B. Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. J Neurosci 2009, 29:6860-6870.
37. Noble W., Planel E., Zehr C., Olm V., Meyerson J., Suleman F., Gaynor K., Wang L., LaFrancois J., Feinstein B., Burns M., Krishnamurthy P., Wen Y., Bhat R., Lewis J., Dickson D., Duff K. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci U S A 2005, 102:6990-6995.
38. Patani R., Balaratnam M., Vora A., Reynolds R. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol Appl Neurobiol 2007, 33:277-287.
39. Patrikios P., Stadelmann C., Kutzelnigg A., Rauschka H., Schmidbauer M., Laursen H., Sorensen P.S., Bruck W., Lucchinetti C., Lassmann H. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006, 129:3165-3172.
40. Ryves W.J., Harwood A.J. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun 2001, 280:720-725.
41. Sadoul R. Bcl-2 family members in the development and degenerative pathologies of the nervous system. Cell Death Differ 1998, 5:805-815.
42. Studzinski D.M., Ramaswamy R., Benjamins J.A. Effects of cyclic AMP on expression of myelin genes in the N20.1 oligodendroglial cell line. Neurochem Res 1998, 23:435-441.
43. Tawk M., Makoukji J., Belle M., Fonte C., Trousson A., Hawkins T., Li H., Ghandour S., Schumacher M., Massaad C. Wnt/beta-catenin signaling is an essential and direct driver of myelin gene expression and myelinogenesis. J Neurosci 2011, 31:3729-3742.
44. Trapp B.D., Nave K.A. Multiple sclerosis: an immune or neurodegenerative disorder?. Annu Rev Neurosci 2008, 31:247-269.
45. Ye F., Chen Y., Hoang T., Montgomery R.L., Zhao X.H., Bu H., Hu T., Taketo M.M., van Es J.H., Clevers H., Hsieh J., Bassel-Duby R., Olson E.N., Lu Q.R. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat Neurosci 2009, 12:829-838.